Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma

Journal of Proteome Research

Volumn 10, Issue 6, 2011, Pages 2863-2872

  Zhang, Jintao ^a,b   Wang, Kaijuan ^a,b   Zhang, Jianzhong ^c   Liu, Samuel S ^b   Dai, Liping ^a   Zhang, Jian Ying ^a,b  

^a ZHENGZHOU UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS AT EL PASO   (United States)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

biomarkers; cancer autoantibody; cancer diagnosis; esophageal squamous cell carcinoma (ESCC); proteomic approach; tumor associated proteins

Indexed keywords

ANNEXIN; ANNEXIN 1; BETA 2 MICROGLOBULIN; BILIVERDIN REDUCTASE B; BIOLOGICAL MARKER; CALRETICULIN; CARBONATE DEHYDRATASE I; COFILIN 1; CYSTATIN B; CYTOKERATIN 13; CYTOKERATIN 17; CYTOKERATIN 19; FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 1A; GLUCOSE REGULATED PROTEIN 78; GLYOXALASE; HEAT SHOCK PROTEIN 70; HIGH MOBILITY GROUP B1 PROTEIN; HISTONE H3; MANGANESE SUPEROXIDE DISMUTASE; OXIDOREDUCTASE; PEROXIREDOXIN 1; POLYUBIQUITIN; PROFILIN; PROTEASOME; PROTEASOME ACTIVATOR SUBUNIT 1; STRATIFIN; TRANSGELIN; TROPOMYOSIN; TROPOMYOSIN 2; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MOTILITY; CELL PROLIFERATION; CLINICAL ARTICLE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEOMICS; SIGNAL TRANSDUCTION; TWO DIMENSIONAL ELECTROPHORESIS;

ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HMGB1 PROTEIN; HSP70 HEAT-SHOCK PROTEINS; HUMANS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 79958241531     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr200141c     Document Type: Article

References (60)

1. Li, J. Y. Epidemiology of esophageal cancer in China J. Natl. Cancer Inst. Monogr. 1982, 62, 113-120 (Pubitemid 13102228)
2. Qiao, Y. L.; Dawsey, S. M.; Kamangar, F.; Fan, J. H.; Abnet, C. C.; Sun, X. D.; Johnson, L, L; Gail, M. H.; Dong, Z. W.; Yu, B.; Mark, S. D.; Taylor, P. R. Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial J. Natl. Cancer Inst. 2009, 101, 507-518
3. Kim, T; Grobmyer, S. R.; Smith, R.; Ben-David, K.; Ang, D.; Vogel, S. B.; Hochwald, S. N. Esophageal cancer-the five year survivors J. Surg. Oncol. 2011, 103, 179-183
4. Law, S.; Wong, J. The current management of esophageal cancer Adv. Surg. 2007, 41, 93-119
5. Kwong, K. F. Molecular biology of esophageal cancer in the genomics era. Surg Clin. North Am. 2005, 85, 539-553 (Pubitemid 40779374)
6. McCabe, M. L.; Dlamini, Z. The molecular mechanisms of oesophageal cancer Int. Immunopharmacol. 2005, 5, 1113-1130 (Pubitemid 40725707)
7. Lin, J.; Beerm, D. G. Molecular biology of upper gastrointestinal malignancies Semin. Oncol. 2004, 31, 476-486 (Pubitemid 39070267)
8. Le Naour, F.; Brichory, F.; Misek, D. E.; Bréchot, C.; Hanash, S. M.; Beretta, L. A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis Mol. Cell. Proteomics 2002, 1, 197-203
9. Wang, K. J.; Wang, R. T.; Zhang, J. Z. Identification of tumor markers using two-dimensi- onal electrophoresis in gastric carcinoma World J. Gastroenterol. 2004, 10, 2179-2183
10. Looi, K. S.; Nakayasu, E. S.; Diaz, R. A.; Tan, E. M.; Almeida, I. C.; Zhang, J. Y. Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma J. Proteome Res. 2008, 7, 4004-4012
11. Bradford, M. M. A rapid and sensitive method for the quantization of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 1976, 72, 248-254
12. Zhang, J. Y.; Casiano, C. A.; Peng, X. X.; Koziol, J. A.; Chan, E. K. L.; Tan, E. M. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens Cancer Epidemiol. Biomarkers Prev. 2003, 12, 136-143 (Pubitemid 36194003)
13. Chariyalertsak, S.; Purisa, W.; Sangrajrang, S. Role of glutathione S-transferase omega gene polymorphisms in breast-cancer risk Tumori 2009, 95, 739-743
14. Yiu, C. C.; Sasano, H.; Ono, K.; Chow, L. W. Changes in protein expression after neoadjuvant use of aromatase inhibitors in primary breast cancer: a proteomic approach to search for potential biomarkers to predict response or resistance Expert Opin. Investig. Drugs 2010, 19 (Suppl 1) S79-89
15. Germanová, A.; Germanová, A.; Tesarová, P.; Jáchymová, M.; Zvára, K.; Zima, T.; Kalousová, M. Glyoxalase I Glu111Ala polymorphism in patients with breast cancer Cancer Invest. 2009, 27, 655-660
16. Flohr, A. M.; Rogalla, P.; Meiboom, M.; Borrmann, L.; Krohn, M.; Thode-Halle, B.; Bullerdiek, J. Variation of HMGB1 expression in breast cancer Anticancer Res. 2001, 21, 3881-3885 (Pubitemid 34229257)
17. Gong, H.; Zuliani, P.; Komuravelli, A.; Faeder, J. R.; Clarke, E. M. Analysis and verification of the HMGB1 signaling pathway BMC Bioinform. 2010, 11 (Suppl 7) S10
18. Zou, L.; Hazan, R.; Roy, P. Profilin-1 overexpression restores adherens junctions in MDA-MB-231 breast cancer cells in R-cadherin-dependent manner Cell Motil. Cytoskeleton 2009, 66, 1048-1056
19. Zou, L.; Ding, Z.; Roy, P. Profilin-1 overexpression inhibits proliferation of MDA-MB-231 breast cancer cells partly through p27kip1 upregulation J. Cell Physiol. 2010, 223, 623-629
20. Dumitrescu, R. G.; Cotarla, I. Understanding breast cancer risk - where do we stand in 2005? J. Cell. Mol. Med. 2005, 9, 208-221
21. Ciocca, D. R.; Calderwood, S. K. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications Cell Stress Chaperones 2005, 10, 86-103 (Pubitemid 40942470)
22. Karihtala, P.; Mäntyniemi, A.; Kang, S. W.; Kinnula, V. L.; Soini, Y. Peroxiredoxins in breast carcinoma Clin. Cancer Res. 2003, 9, 3418-3424 (Pubitemid 37082738)
23. Cha, M. K.; Suh, K. H.; Kim, I. H. Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma J. Exp. Clin. Cancer Res. 2009, 28, 93
24. Nair, S.; Hande, M. P.; Lim, L. H. Annexin-1 protects MCF7 breast cancer cells against heat-induced growth arrest and DNA damage Cancer Lett. 2010, 294, 111-117
25. Ang, E. Z.; Nguyen, H. T.; Sim, H. L.; Putti, T. C.; Lim, L. H. Annexin-1 regulates growth arrest induced by high levels of estrogen in MCF-7 breast cancer cells Mol. Cancer Res. 2009, 7, 266-274
26. Xu, S. G.; Yan, P. J.; Shao, Z. M. Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis J. Cancer Res. Clin. Oncol. 2010, 136, 1545-1556
27. Tjensvoll, K.; Oltedal, S.; Farmen, R. K.; Shammas, F. V.; Heikkilä, R.; Kvaløy, J. T.; Gilje, B.; Smaaland, R.; Nordgård, O. Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients Clin. Breast Cancer 2010, 10, 378-384
28. Bateman, N. W.; Sun, M.; Hood, B. L.; Flint, M. S.; Conrads, T. P. Defining central themes in breast cancer biology by differential proteomics: conserved regulation of cell spreading and focal adhesion kinase J. Proteome Res. 2010, 9, 5311-5324
29. Xu, Y.; Zhang, S. Z.; Huang, C. H.; Liu, X. Y.; Zhong, Z. H.; Hou, W. L.; Su, Z. F.; Wei, Y. Q. Keratin 17 identified by proteomic analysis may be involved in tumor angiogenesis BMB Rep. 2009, 42, 344-349
30. Melle, C.; Ernst, G.; Scheibner, O.; Kaufmann, R.; Schimmel, B.; Bleul, A.; Settmacher, U.; Hommann, M.; Claussen, U.; von Eggeling, F. Identification of specific protein markers in microdissected hepatocellular carcinoma J. Proteome Res. 2007, 6, 306-315 (Pubitemid 46173682)
31. Li, N.; Zhang, J.; Liang, Y.; Shao, J.; Peng, F.; Sun, M.; Xu, N.; Li, X.; Wang, R.; Liu, S.; Lu, Y. A controversial tumor marker: is SM22 a proper biomarker for gastric cancer cells? J. Proteome Res. 2007, 6, 3304-3312 (Pubitemid 47310214)
32. Klade, C. S.; Voss, T.; Krystek, E.; Ahorn, H.; Zatloukal, K.; Pummer, K.; Adolf, G. R. Identification of tumor antigens in renal cell carcinoma by serological proteome analysis Proteomics 2001, 1, 890-898 (Pubitemid 33587414)
33. Feldman, A. S.; Banyard, J.; Wu, C. L.; McDougal, W. S.; Zetter, B. R. Cystatin B as a tissue and urinary biomarker of bladder cancer recurrence and disease progression Clin. Cancer Res. 2009, 15, 1024-1031
34. Lee, M. J.; Yu, G. R.; Park, S. H.; Cho, B. H.; Ahn, J. S.; Park, H. J.; Song, E. Y.; Kim, D. G. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma Clin. Cancer Res. 2008, 14, 1080-1089
35. Ren, H. Z.; Pan, G. Q.; Wang, J. S.; Wen, J. F.; Wang, K. S.; Luo, G. Q.; Shan, X. Z. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma Dig. Dis. Sci. 2010, 55, 2552-2560
36. Basu, A.; Banerjee, H.; Rojas, H.; Martinez, S. R.; Roy, S.; Jia, Z.; Lilly, M. B.; De León, M.; Casiano, C. A. Differential expression of peroxiredoxins in prostate cancer: Consistent upregulation of PRDX3 and PRDX4. Prostate 2010, in press.
37. Cecconi, D.; Astner, H.; Donadelli, M.; Palmieri, M.; Missiaglia, E.; Hamdan, M.; Scarpa, A.; Righetti, P. G. Proteomic analysis of pancreatic ductal carcinoma cells treated with 5-aza-2′-deoxycytidine Electrophoresis 2003, 24, 4291-4303 (Pubitemid 38094474)
38. Ciocca, D. R.; Clark, G. M.; Tandon, A. K.; Fuqua, S. A.; Welch, W. J.; McGuire, W. L. Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications J. Natl. Cancer Inst. 1993, 85, 570-574 (Pubitemid 23110932)
39. Lazaris, A.; Chatzigianni, E. B.; Panoussopoulos, D.; Tzimas, G. N.; Davaris, P. S.; Golematis, B. Proliferating cell nuclear antigen and heat shock protein 70 immunolocalization in invasive ductal breast cancer not otherwise specified Breast Cancer Res. Treat. 1997, 43, 43-51 (Pubitemid 27090866)
40. Vargas-Roig, L. M.; Gago, F. E.; Tello, O.; Aznar, J. C.; Ciocca, D. R. Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy Int. J. Cancer 1998, 79, 468-475 (Pubitemid 28445267)
41. Rohde, M.; Daugaard, M.; Jensen, M. H.; Helin, K.; Nylandsted, J.; Jaattela, M. Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanisms Genes Dev. 2005, 19, 570-582 (Pubitemid 40314989)
42. Powers, M. V.; Clarke, P. A.; Workman, P. Death by chaperone: HSP90, HSP70 or both? Cell Cycle 2009, 8, 518-526
43. Fujita, Y.; Nakanishi, T.; Miyamoto, Y.; Hiramatsu, M.; Mabuchi, H.; Miyamoto, A.; Shimizu, A.; Takubo, T.; Tanigawa, N. Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma Cancer Lett. 2008, 263, 280-290
44. Tong, Y. Q.; Zhang, Z. J.; Liu, B.; Huang, J.; Liu, H.; Liu, Y.; Guo, F. J.; Zhou, G. H.; Xie, P. L.; Li, Y. H.; Zuo, C. H.; Hu, J. Y.; Li, G. C. Autoantibodies as potential biomarkers for nasopharyngeal carcinoma Proteomics 2008, 8, 3185-3193
45. Shukla, S.; Pranay, A.; D'Cruz, A. K.; Chaturvedi, P.; Kane, S. V.; Zingde, S. M. Immunoproteomics reveals that cancer of the tongue and the gingivobuccal complex exhibit differential autoantibody response Cancer Biomark. 2009, 5, 127-135
46. Lotze, M. T.; Tracey, K. J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal Nat. Rev., Immunol. 2005, 5, 331-342 (Pubitemid 40516158)
47. Muller, S.; Scaffidi, P.; Degryse, B.; Bonaldi, T.; Ronfani, L.; Agresti, A.; Beltrame, M.; Bianchi, M. E. New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal EMBO J. 2001, 20, 4337-4340 (Pubitemid 32772027)
48. Dong, Xda. E.; Ito, N.; Lotze, M. T.; Demarco, R. A.; Popovic, P.; Shand, S. H.; Watkins, S.; Winikoff, S.; Brown, C. K.; Bartlett, D. L.; Zeh, H. J. 3rd. High mobility group box I (HMGB1) release from tumor cells after treatment: implications for development of targeted chemoimmunotherapy J. Immunother. 2007, 30, 596-606 (Pubitemid 47229694)
49. Ellerman, J. E.; Brown, C. K.; de Vera, M.; Zeh, H. J.; Billiar, T.; Rubartelli, A.; Lotze, M. T. Masquerader: high mobility group box-1 and cancer Clin. Cancer Res. 2007, 13, 2836-2848 (Pubitemid 46850704)
50. Tang, D.; Kang, R.; Zeh, H. J., 3rd.; Lotze, M. T. High-mobility group box 1 and cancer Biochim. Biophys. Acta 2010, 1799, 131-140
51. Andersson, U.; Harris, H. E. The role of HMGB1 in the pathogenesis of rheumatic disease Biochim. Biophys. Acta 2010, 1799, 141-148
52. Hayashi, A.; Nagafuchi, H.; Ito, I.; Hirota, K.; Yoshida, M.; Ozaki, S. Lupus antibodies to the HMGB1 chromosomal protein: epitope mapping and association with disease activity Mod. Rheumatol. 2009, 19, 283-292
53. Urbonaviciute, V.; Fürnrohr, B. G.; Meister, S.; Munoz, L.; Heyder, P.; De Marchis, F.; Bianchi, M. E.; Kirschning, C.; Wagner, H.; Manfredi, A. A.; Kalden, J. R.; Schett, G.; Rovere-Querini, P.; Herrmann, M.; Voll, R. E. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE J. Exp. Med. 2008, 205, 3007-3018
54. Kusume, A.; Sasahira, T.; Luo, Y.; Isobe, M.; Nakagawa, N.; Tatsumoto, N.; Fujii, K.; Ohmori, H.; Kuniyasu, H. Suppression of dendritic cells by HMGB1 is associated with lymph node metastasis of human colon cancer Pathobiology 2009, 76, 155-162
55. Shen, X.; Hong, L.; Sun, H.; Shi, M.; Song, Y. The expression of high-mobility group protein box 1 correlates with the progression of non-small cell lung cancer Oncol. Rep. 2009, 22, 535-539
56. Gong, H.; Zuliani, P.; Komuravelli, A.; Faeder, J. R.; Clarke, E. M. Analysis and verification of the HMGB1 signaling pathway BMC Bioinform. 2010, 11 (Suppl 7) S10
57. Zhang, J. Y. Tumor-associated antigen array to enhance antibody detection for cancer diagnosis Cancer Detect. Prev. 2004, 28, 114-118
58. Casiano, C. A.; Mediavilla-Varela, M.; Tan, E. M. Tumor-associated antigen arrays for the serological diagnosis of cancer Mol. Cell. Proteomics 2006, 5, 1745-59 (Pubitemid 44688185)
59. Tan, E. M.; Zhang, J. Autoantibodies to tumor-associated antigens: reporters from the immune system Immunol. Rev. 2008, 222, 328-340 (Pubitemid 351430373)
60. Zhang, J. Y.; Tan, E. M. Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors Expert Rev. Mol. Diagn. 2010, 10, 321-328